2Schror K, Hohlfeld T. Mechanisms of anti 2 ischemic action of prostaglandin E1 in peripheral arterial occlusive disease[J].Vasa, 2004, 33(3):119-124.
二级参考文献2
1[1]Amos AF, McCarty PJ, Zimmet P. The rising global burden of diabetes and its complications. Estimates and projections to the year 2010,Diab Med,1997,7:85.
2[4]Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers:The world health organization multinational study of vascular disease in diabetics. Diabetologia. 1985,28:615～640.
8Moro MA, De Alba J, Cardenas A, et al. Mechanisms of the neuro - protective effect of aspirin after oxygen and glucose depri- vation in rat forebrain slicea [ J ]. Neuropharmacology, 2000, 39 (7): 1309-1318.
9Femdndez T. Inhibition of glutmnate release via recovery of ATP levels accounts for a neurons exposed to oxygen - glucose depriva- tion neuroprotective effect of aspirinin rat cortex [ J ]. Stroke, 2002, 33 (2): 261-267.
10Castillo J, Leira R, Moro MA, et al. Neuroprotective effects of aspirin in patients with acute cerebral infarction [ J . Neu- rosci Lett, 2003, 339 (3): 248.
